Publications by authors named "Ruth Lock"

Claim this Profile
M
Mass Balance Recovery, Absorption, Metabolism, and Excretion of Elinzanetant in Healthy Human Volunteers and in vitro Biotransformation.
Simone I Schulz, Marcus-Hillert Schultze-Mosgau, Anna Engelen, Nand Singh, Steve Pawsey, Ruth Lock

Eur J Drug Metab Pharmacokinet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK-954).
Richard Czerniak, Blanka Cieslarová, Viera Kupčová, Maria Rosario, Ruth Lock

J Clin Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Pharmacokinetics of Felcisetrag (TAK-954), a 5-HT Receptor Agonist, in the Presence and Absence of Itraconazole, a Potent CYP3A4 Inhibitor.
Chunlin Chen, Liming Zhang, Cristina Almansa, Maria Rosario, Michael Cwik, Ruth Lock

Clin Pharmacol Drug Dev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis.
Steven M Rowe, Ginger Reeves, Heather Hathorne, G Martin Solomon, Smita Abbi, Ruth Lock

Chest· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in inhaled product development and opportunities for open innovation.
Ben Forbes, Bahman Asgharian, Lea Ann Dailey, Douglas Ferguson, Per Gerde, Ruth Lock

Adv Drug Deliv Rev· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for respiratory diseases.
Ruth Lock, Steve Collingwood, Andrew Ratcliffe

Drug News Perspect· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis